113 related articles for article (PubMed ID: 22297560)
1. Protein Z concentrations in patients with acute leukemia.
Galar M; Piszcz J; Bolkun L; Szumowska A; Kloczko J
Clin Appl Thromb Hemost; 2012 Sep; 18(5):542-5. PubMed ID: 22297560
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentration of protein Z and protein Z-dependent protease inhibitor in patients with haemophilia A.
Bolkun L; Galar M; Piszcz J; Lemancewicz D; Kloczko J
Thromb Res; 2013 Mar; 131(3):e110-3. PubMed ID: 23269381
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of protein Z detection in patients with malignant tumors].
Shang Y; Pan XY; Ding CP; Yang XM; Cai XY; Ding Y; Zhang RL
Ai Zheng; 2005 Sep; 24(9):1144-7. PubMed ID: 16159443
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal manifestations as initial presentation of acute leukemias in children and adolescents.
Robazzi TC; Silva LR; Mendonça N; Barreto JH
Acta Gastroenterol Latinoam; 2008 Jun; 38(2):126-32. PubMed ID: 18697407
[TBL] [Abstract][Full Text] [Related]
5. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
[TBL] [Abstract][Full Text] [Related]
6. Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML).
Ravandi F; Jilani I; Estey E; Kantarjian H; Dey A; Aguilar C; Jitkaroon C; Giles F; O'Brien S; Keating M; Albitar M
Leuk Res; 2007 Jun; 31(6):791-7. PubMed ID: 17156841
[TBL] [Abstract][Full Text] [Related]
7. Hypercoagulable state and hemorrhage in acute leukemias.
He LZ; Lu LH
Chin Med J (Engl); 1988 Jun; 101(6):448-53. PubMed ID: 3146479
[No Abstract] [Full Text] [Related]
8. Protein C and antithrombin III in children with acute leukemia.
Atlihan F; Karakaş Z; Batun S
Turk J Pediatr; 1993; 35(1):45-51. PubMed ID: 8236517
[TBL] [Abstract][Full Text] [Related]
9. Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis.
Pardos-Gea J; Ordi-Ros J; Serrano S; Balada E; Nicolau I; Vilardell M
Thromb Res; 2008; 121(6):727-34. PubMed ID: 17869328
[TBL] [Abstract][Full Text] [Related]
10. Protein Z is reduced in chronic kidney disease and not elevated in patients on haemodialysis.
Blyth E; Favaloro EJ; Harris D; Kairaitis L
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):23-5. PubMed ID: 18180611
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of telomerase activity levels in acute leukemia.
Ohyashiki JH; Ohyashiki K; Iwama H; Hayashi S; Toyama K; Shay JW
Clin Cancer Res; 1997 Apr; 3(4):619-25. PubMed ID: 9815729
[TBL] [Abstract][Full Text] [Related]
12. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietic activities in acute leukemia and in malignant lymphoma with or without bone marrow involvement.
Choi JW; Pai SH
Ann Clin Lab Sci; 2003; 33(4):407-10. PubMed ID: 14584754
[TBL] [Abstract][Full Text] [Related]
14. [Association of acute leukemia with disseminated intravascular coagulation in adults. Analysis of 14 cases].
Zuazu I; Canals C; Sempere A; Martín S; Brunet S; Puig J; Fontcuberta J; Grau E
Med Clin (Barc); 1989 Oct; 93(12):441-4. PubMed ID: 2607808
[TBL] [Abstract][Full Text] [Related]
15. Roles of protein C, protein S, and antithrombin III in acute leukemia.
Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
[TBL] [Abstract][Full Text] [Related]
16. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H
Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376
[TBL] [Abstract][Full Text] [Related]
17. [Tumor necrosis factor alpha activity in peripheral blood in patients with acute leukemia: changes and clinical implications].
Zeng B
Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):405-7, 446. PubMed ID: 1330229
[TBL] [Abstract][Full Text] [Related]
18. [Plasma concentration of the shed form of L-selectin (sL-selectin) in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) and its relation to the clinical course].
Kapelko-Slowik K; Jaźwiec B; Mirosław S; Wołowiec D; Urbaniak-Kujda D; Tomaszewska-Toporska B; Potoczek S; Ciszak L; Kuliczkowski K
Pol Arch Med Wewn; 2004 Nov; 112(5):1283-8. PubMed ID: 15773509
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of the detection of the sL-selectin level in patients with acute leukemia].
Chang JH; Qi ZH; Xu M
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):151-3. PubMed ID: 12575346
[TBL] [Abstract][Full Text] [Related]
20. Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia.
Moon Y; Kim Y; Kim M; Lim J; Kang CS; Kim WI; Shim SI; Chung NG; Park YH; Min WS; Han K
Ann Clin Lab Sci; 2004; 34(4):410-5. PubMed ID: 15648782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
